Data from a phase 1 trial suggest that durable, vaccine-induced T-cell memory may be achievable even...
HEALTH NEWS
April 22, 2026
Autogene Cevumeran & The Future of Personalized Cancer Vaccines
Data from a phase 1 trial suggest that durable, vaccine-induced T-cell memory may be achievable even in pancreatic ductal adenocarcinoma.
1 views
0 likes
0 comments
Data from a phase 1 trial suggest that durable, vaccine-induced T-cell memory may be achievable even in pancreatic ductal adenocarcinoma.
Author: CancerNetwork
Read Original Article
